Device Trial Radar · NCT06217328
RESTORE: An RCT to Evaluate the Efficacy of the Revi System
Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
117
Actual
Start
Feb 24, 2024
Primary completion
Feb 28, 2026
Study completion Feb 28, 2027
Sponsor
- Lead sponsor
- BlueWind MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 22, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The Revi System is indicated for the treatment of patients with symptoms of urgency incontinence alone or in combination with urinary urgency.
Conditions
- Urinary Urge Incontinence
Interventions
Revi System TreatmentDevice
The Revi System is an implantable neuromodulation device placed in the ankle region that is activated by a battery-operated rechargeable external wearable
Revi System - Delayed ActivationDevice
The Revi System is an implantable neuromodulation device placed in the ankle region that is activated by a battery-operated rechargeable external wearable. The system will be implanted but it will not be turned on until 4 months post implant procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary EndpointTime frame: Month 4
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Arizona Urology Specialists
Tucson, Arizona
Pasadena Urology
Pasadena, California
Riverside Medical Clinic
Riverside, California
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.